{
  "report_rows": [
    {
      "kpi": "Q2 2026 total revenue",
      "prediction": "BEAT",
      "answer": "pred ~$799M vs. cons $787.4M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 U.S. Omnipod revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$543M vs. cons $540M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.52 vs. cons $1.45",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 total revenue",
      "prediction": "LOWER",
      "answer": "guide ~$842M vs. cons $845M (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2026 total revenue",
      "prediction": "BETTER",
      "answer": "guide ~$3.35B vs. cons $3.32B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted diluted EPS",
      "prediction": "LOWER",
      "answer": "guide >~$6.21 vs. cons $6.48 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 8.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FADE",
  "day5_rationale": "A clean demand-driven revenue beat and contained correction commentary should trigger an initial relief rally, but Q3 revenue near ~$842M versus ~$845M consensus and an unchanged >~$6.21 FY2026 EPS floor versus $6.48 consensus would limit upward revisions and cause part of the day-1 move to fade.",
  "day5_confidence": "MEDIUM"
}